Abstract 366: A novel transcript variant of androgen receptor identified in circulating tumor cells from castration-resistant prostate cancer patients as a potentially prognostic biomarker

Novel Transcript ◽

Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients

Prostate Cancer and Prostatic Diseases ◽

10.1038/s41391-018-0043-z ◽

2018 ◽

Vol 21 (3) ◽

pp. 411-418 ◽

Cited By ~ 12

Author(s):

Manish Kohli ◽

Jian Li ◽

Meijun Du ◽

David W Hillman ◽

Scott M. Dehm ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Plasma Cell ◽

Castration Resistant ◽

Free Dna ◽

Prognostic Association

Apostream to isolate circulating tumor cells (CTC) from castration-resistant prostate cancer patients (CRPC) that express androgen receptor variant 7 (AR-V7) associated with resistance to AR-targeting drugs.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e23025 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e23025-e23025

Author(s):

Darren W. Davis ◽

Asifa Haider ◽

Valerie Pierron ◽

Fabien Schmidlin

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving 177Lu-PSMA-617 Radioligand Therapy

Theranostics ◽

10.7150/thno.44556 ◽

2020 ◽

Vol 10 (17) ◽

pp. 7645-7655

Author(s):

Katharina Kessel ◽

Robert Seifert ◽

Matthias Weckesser ◽

Wolfgang Roll ◽

Verena Humberg ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Molecular Analysis ◽

Radioligand Therapy ◽

Dynamic variations in gene expressions of circulating tumor cells in metastatic castration-resistant prostate cancer patients in response to androgen receptor signaling inhibitors.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e17063 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e17063-e17063

Author(s):

Yu Jen Jan ◽

Sungyong You ◽

Junhee Yoon ◽

Jie-Fu Chen ◽

Nu Yao ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Cancer Patients ◽

Tumor Cells ◽

Gene Expressions ◽

Androgen Receptor Signaling ◽

Castration Resistant ◽

Dynamic Variations ◽

Signaling Inhibitors

Androgen receptor (AR) activation levels on circulating tumor cells (CTCs) to predict response to second-line therapy in castration-resistant prostate cancer (CRPC)

Science-Business eXchange ◽

10.1038/scibx.2012.1168 ◽

2012 ◽

Vol 5 (44) ◽

pp. 1168-1168

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Second Line ◽

Second Line Therapy ◽

Castration Resistant ◽

Line Therapy

615P Circulating tumor cells (CTC) gene expression and plasma androgen receptor (AR) copy number (CN) in cabazitaxel-treated metastatic castration-resistant prostate cancer (mCRPC)

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1128 ◽

2021 ◽

Vol 32 ◽

pp. S654-S655

Author(s):

G. Gurioli ◽

V. Conteduca ◽

N. Brighi ◽

E. Scarpi ◽

U. Basso ◽

...

Keyword(s):

Gene Expression ◽

Prostate Cancer ◽

Androgen Receptor ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Copy Number ◽

Abstract 4971: Quantitative image analysis of androgen receptor (AR) and tubulin biomarker profiles in circulating tumor cells (CTCs) from metastatic castration resistant prostate cancer (mCRPC) patients

10.1158/1538-7445.am2016-4971 ◽

2016 ◽

Author(s):

Daniel Worroll ◽

Giuseppe Galletti ◽

David M. Nanus ◽

Scott T. Tagawa ◽

Paraskevi Giannakakou

Keyword(s):

Prostate Cancer ◽

Image Analysis ◽

Androgen Receptor ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Quantitative Image Analysis ◽

Castration Resistant ◽

Quantitative Image

Abstract 3196: Analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRLX301, a nanoparticle of docetaxel

10.1158/1538-7445.am2020-3196 ◽

2020 ◽

Author(s):

Eiman Mukhtar ◽

Daniel Worroll ◽

Giuseppe Galletti ◽

Shelly Schuster ◽

Sarina A. Piha-Paul ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Drug Target ◽

Target Engagement ◽

TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate

European Urology ◽

10.1016/j.eururo.2011.07.011 ◽

2011 ◽

Vol 60 (5) ◽

pp. 897-904 ◽

Cited By ~ 147

Author(s):

Daniel C. Danila ◽

Aseem Anand ◽

Clifford C. Sung ◽

Glenn Heller ◽

Margaret A. Leversha ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Predictive Biomarker ◽

Abiraterone Acetate ◽

Abstract 4815: A novel AR splice variant identified in circulating tumor cells from castration-resistant prostate cancer patient blood as a potentially prognostic biomarker

10.1158/1538-7445.am2014-4815 ◽

2014 ◽

Author(s):

Zhigang Kang ◽

Yunkai Yu ◽

Liang Cao ◽

Paul S. Meltzer ◽

Yuelin Zhu ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patient ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Splice Variant ◽

Prostate Cancer Patient ◽

Prognostic Biomarker ◽